Charles Schwab reported record second-quarter revenue of $7.1 billion and earnings, beating analyst expectations, driven by a surge in client trading activity and new accounts. Despite these strong results and an upward revision of its full-year revenue guidance, Schwab's stock fell by 2.5%. The company also expanded its offerings with Schwab Crypto for spot trading and a generative AI tool called Portfolio Insights.

Rocket Lab (RKLB) has fallen 55% from its peak due to sector rotation, despite strong fundamental improvements including a $266 million Air Force contract, a role in a $17 billion Space Force ceiling agreement, and a proposed $8 billion acquisition of Iridium Communications. Analysts maintain a bullish outlook with an average price target of $116.57, and investors are awaiting the August 6 earnings call for more details on the Iridium integration and financing.

This article examines the hypothetical investment of $1000 in Arista Networks (ANET) ten years ago, calculating its current worth. As of July 22, 2026, the initial $1000 investment would be valued at $39,694.41, representing a gain of 3,869.44%. The piece also discusses Arista Networks' business, including its cloud networking solutions and future growth prospects, while acknowledging competitive challenges.

Citizens Jmp downgraded Pegasystems (NASDAQ:PEGA) from an "outperform" to a "market perform" rating. This news follows a trend of other downgrades and reaffirmations from various brokerages, setting the company's average rating at "Moderate Buy" with a target price of $63.30. Pegasystems recently reported Q2 earnings of $0.35 per share, missing the consensus estimate, and had revenue of $420.72 million.

Morgan Stanley downgraded Elastic (ESTC) due to concerns about slower AI search growth, increased security competition, and recent leadership changes, prompting investors to re-evaluate its risk profile. Despite a strong recent share price run, its one-year return has declined, highlighting a contrast between short-term momentum and long-term performance. Investors are now left to consider if the stock's current valuation compensates for these identified competitive and execution risks.

Intel's Foundry unit has partnered with Fortinet to co-develop the Fortinet Security Processor 6 (SP6), a custom chip for cybersecurity, utilizing Intel's 7nm process technology. This collaboration combines Fortinet's security processor expertise with Intel's design and manufacturing capabilities, aiming to accelerate the development of critical security technologies and strengthen the global semiconductor supply chain. This partnership follows other recent Intel collaborations aimed at bolstering its foundry business, including deals with Google and involvement in Elon Musk's 'TeraFab' project.

Trinity Biotech and Latch Medical have formed a strategic collaboration and equity investment to advance biosensor-guided precision drug delivery solutions. The partnership aims to integrate Trinity Biotech's AI-native CGM+ wearable biosensor platform with Latch Medical's intradermal drug delivery technology, Pharma Latch™, to develop next-generation metabolic health solutions for diabetes, obesity, and other related conditions. This collaboration seeks to create more personalized and responsive treatment approaches by using real-time metabolic data to guide and optimize therapeutic delivery.

B. Riley has revised its price target for Amkor Technology, Inc. (AMKR) downwards to $75 from its previous $90 target, while maintaining a Neutral rating on the stock. This adjustment comes despite a recent uptick in Amkor's stock following a partnership announcement with Taiwan Semiconductor, suggesting a cautious outlook from the analyst firm. Amkor Technology is a provider of outsourced semiconductor packaging and test services, with recent news including insider stock sales and expansion of its Arizona operations.

The Sandwich City Council has approved a 10-year, $720,475.50 agreement with Axon Enterprise Inc. for police body cameras, Tasers, license plate technology, and digital evidence services through 2035. This agreement upgrades existing equipment and adds features like translation and automated video-redaction capabilities, which will assist with Freedom of Information Act requests. The first payment will be $1,000, followed by nine annual payments of $79,941.72.

West Pharmaceutical Services (WST) is set to announce its Q2 earnings before the market open tomorrow. The company beat revenue and EPS expectations last quarter, and analysts anticipate 9.9% year-on-year revenue growth this quarter. Investor sentiment for life sciences tools & services stocks has been positive, with West Pharmaceutical Services' shares up 8.2% in the last month.